Extra Space Storage, Inc. vs Organon & Co. Common Stock — how do they compare? Extra Space Storage, Inc. trades at $135.18 (market cap $28.26B), while Organon & Co. Common Stock trades at $13.58 (market cap $3.62B). The key difference: Extra Space Storage, Inc. is far larger — about 7.8× Organon & Co. Common Stock's market cap, and Extra Space Storage, Inc. pays the higher dividend (4.85%). Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Organon & Co. Common Stock for 0 Days on average.
| EXR | OGN | |
|---|---|---|
Market Cap | $28.26B | $3.62B |
Volume | 1,443,466 | 2,892,999 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $13.81 |
52-Week Low | $126.67 | $5.70 |
Typical Hold Time | 109 Days | 0 Days |
Enterprise Value | $41.97B | $11.04B |
Dividend Yield | 4.85% | 0.58% |
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $134.06, up slightly by 0.01% today, with a neutral technical signal and bearish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38 billion in 2025, and net income reached $974 million, supported by a robust gross margin of 70.78%. Analyst consensus is evenly split between Buy and Hold, with a price target of $158.33, suggesting potential upside. Recent news highlights leadership transitions and steady dividend payments.
Outlook: EXR shows solid operational performance and financial flexibility, but faces risks from high leverage and softer housing demand. The stock's valuation metrics like P/E of 29.52 and EV/EBITDA of 17.35 indicate premium pricing. Investment opportunity lies in sustained earnings growth and dividend yield, while risks include interest rate sensitivity and competitive pressures in the REIT sector.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →